Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Accendra Health (ACH) Net Income towards Common Stockholders (2016 - 2025)

Historic Net Income towards Common Stockholders for Accendra Health (ACH) over the last 16 years, with Q3 2025 value amounting to -$144.7 million.

  • Accendra Health's Net Income towards Common Stockholders fell 93106.69% to -$144.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.4 billion, marking a year-over-year decrease of 240126.09%. This contributed to the annual value of -$414.9 million for FY2024, which is 69781.38% down from last year.
  • Latest data reveals that Accendra Health reported Net Income towards Common Stockholders of -$144.7 million as of Q3 2025, which was down 93106.69% from -$785.2 million recorded in Q2 2025.
  • Accendra Health's Net Income towards Common Stockholders' 5-year high stood at $39.3 million during Q1 2022, with a 5-year trough of -$785.2 million in Q2 2025.
  • For the 4-year period, Accendra Health's Net Income towards Common Stockholders averaged around -$96.7 million, with its median value being -$24.4 million (2023).
  • As far as peak fluctuations go, Accendra Health's Net Income towards Common Stockholders skyrocketed by 11061.12% in 2023, and later tumbled by 569542.24% in 2024.
  • Accendra Health's Net Income towards Common Stockholders (Quarter) stood at -$66.7 million in 2022, then surged by 110.61% to $7.1 million in 2023, then crashed by 5695.42% to -$396.0 million in 2024, then skyrocketed by 63.47% to -$144.7 million in 2025.
  • Its Net Income towards Common Stockholders was -$144.7 million in Q3 2025, compared to -$785.2 million in Q2 2025 and -$25.0 million in Q1 2025.